Weyer Camilla T, Grewar John D, Burger Phillippa, Rossouw Esthea, Lourens Carina, Joone Christopher, le Grange Misha, Coetzee Peter, Venter Estelle, Martin Darren P, MacLachlan N James, Guthrie Alan J
Emerg Infect Dis. 2016 Dec;22(12):2087-2096. doi: 10.3201/eid2212.160718. Epub 2016 Dec 15.
African horse sickness (AHS) is a hemorrhagic viral fever of horses. It is the only equine disease for which the World Organization for Animal Health has introduced specific guidelines for member countries seeking official recognition of disease-free status. Since 1997, South Africa has maintained an AHS controlled area; however, sporadic outbreaks of AHS have occurred in this area. We compared the whole genome sequences of 39 AHS viruses (AHSVs) from field AHS cases to determine the source of 3 such outbreaks. Our analysis confirmed that individual outbreaks were caused by virulent revertants of AHSV type 1 live, attenuated vaccine (LAV) and reassortants with genome segments derived from AHSV types 1, 3, and 4 from a LAV used in South Africa. These findings show that despite effective protection of vaccinated horses, polyvalent LAV may, paradoxically, place susceptible horses at risk for AHS.
非洲马瘟(AHS)是一种马的出血性病毒性发热疾病。它是世界动物卫生组织针对寻求官方无病状态认可的成员国引入特定指导方针的唯一马类疾病。自1997年以来,南非一直设有非洲马瘟控制区;然而,该地区仍不时爆发非洲马瘟。我们比较了39株来自非洲马瘟现场病例的病毒(AHSV)的全基因组序列,以确定其中3次此类疫情的源头。我们的分析证实,个别疫情是由1型非洲马瘟病毒活疫苗(LAV)的强毒回复株以及与南非使用的一种LAV中源自1、3和4型非洲马瘟病毒的基因组片段的重配体引起的。这些发现表明,尽管接种疫苗的马匹得到了有效保护,但多价LAV可能反常地使易感马匹面临感染非洲马瘟的风险。